On 24 April 2024, the European Commission (‘the Commission’) initiated, on its own initiative, an investigation pursuant to Article 5(1) of the IPI Regulation concerning measures and practices of the People’s Republic of China (‘the PRC’) resulting in a serious and recurrent impairment of access of Union economic operators, goods and services to the PRC’s public procurement market for medical devices. To this end, the Commission published a Notice of Initiation in the Official Journal of the European Union [Notice of initiation of an investigation pursuant to the International Procurement Instrument concerning measures and practices of the People’s Republic of China in the public procurement market for medical devices (OJ C, C/2024/2973, 24.4.2024, ELI: http://data.europa.eu/eli/C/2024/2973/oj).] (‘the Notice of Initiation’).
1. PROCEDURE › 1.1. IPI investigation and consultations, Regulation (EU) 2025/1197
In forcesince 19 Jun 2025